Cantor Fitzgerald Reiterates Overweight on Merck & Co, Maintains $135 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Merck & Co (NYSE:MRK) and maintained a price target of $135.
November 29, 2023 | 2:24 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen reaffirmed an Overweight rating on Merck & Co, with a price target of $135.
The reiteration of an Overweight rating by a prominent analyst could positively influence investor sentiment and potentially lead to a short-term increase in the stock price. The maintained price target suggests a level of confidence in the company's future performance and valuation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100